These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36824609)

  • 21. Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydria.
    Doki K; Darwich AS; Patel N; Rostami-Hodjegan A
    Eur J Pharm Sci; 2017 Nov; 109():111-120. PubMed ID: 28774813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro-In vivo Relationship and Bioequivalence Prediction for Modified-Release Capsules Based on a PBPK Absorption Model.
    Jereb R; Opara J; Legen I; Petek B; Grabnar-Peklar D
    AAPS PharmSciTech; 2019 Dec; 21(1):18. PubMed ID: 31820131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.
    Khoubnasabjafari M; Rahimpour E; Samini M; Jouyban-Gharamaleki V; Chen L; Chen D; Chan HK; Jouyban A
    Daru; 2019 Jun; 27(1):517-524. PubMed ID: 30847847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib.
    Lin L; Wright MR; Hop CECA; Wong H
    Drug Metab Dispos; 2022 Sep; 50(9):1170-1181. PubMed ID: 35779865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling.
    Medeiros JJS; Costa TM; Carmo MP; Nascimento DD; Lauro ENC; Oliveira CA; Duque MD; Prado LD
    Drug Dev Ind Pharm; 2022 Apr; 48(4):146-157. PubMed ID: 35876070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma.
    Ulrik CS; Backer V; Bach-Mortensen N
    Allergy; 1992 Apr; 47(2 Pt 2):133-7. PubMed ID: 1387512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
    Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
    Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Particle Size Distribution Equivalency as Novel Predictors for Bioequivalence.
    Ngeacharernkul P; Stamatis SD; Kirsch LE
    AAPS PharmSciTech; 2018 Oct; 19(7):2787-2800. PubMed ID: 30117041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of physiologically based pharmacokinetic models coupled with pharmacodynamic models to assess the clinical relevance of current bioequivalence criteria for generic drug products containing Ibuprofen.
    Cristofoletti R; Dressman JB
    J Pharm Sci; 2014 Oct; 103(10):3263-75. PubMed ID: 25043938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficiency of a New Mesh-Type Nebulizer (NE-SM1 NEPLUS) for Intrapulmonary Delivery of Ipratropium Bromide in Surgical Patients.
    Lee YH; Kwon GY; Park DY; Bang JY; Jang DM; Lee SH; Lee EK; Choi BM; Noh GJ
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):313-9. PubMed ID: 26440415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of Orally Inhaled Drug Products.
    Hochhaus G; Horhota S; Hendeles L; Suarez S; Rebello J
    AAPS J; 2015 May; 17(3):769-75. PubMed ID: 25762449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the Pharmacokinetics of Orally Administered Drugs across BCS Classes 1-4 by Virtual Bioequivalence Model.
    Zhang F; Wu X; Wu K; Yu M; Liu B; Wang H
    Mol Pharm; 2023 Jan; 20(1):395-408. PubMed ID: 36469444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence Requirements for Orally Inhaled and Nasal Drug Products and Use of Novel Physiologically Based Biopharmaceutics Modeling Approaches for Assessing In Vivo Performance.
    Rachapally A; Boddu R; Kollipara S; Ahmed T
    J Pharm Sci; 2024 Oct; ():. PubMed ID: 39414080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model.
    Saadeddin A; Purohit V; Huh Y; Wong M; Maulny A; Dowty ME; Sagawa K
    AAPS J; 2024 Jan; 26(1):17. PubMed ID: 38267790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Physiologically Based Pharmacokinetic Model for Naphthalene With Inhalation and Skin Routes of Exposure.
    Kapraun DF; Schlosser PM; Nylander-French LA; Kim D; Yost EE; Druwe IL
    Toxicol Sci; 2020 Oct; 177(2):377-391. PubMed ID: 32687177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling.
    Eriksson J; Thörn H; Lennernäs H; Sjögren E
    Eur J Pharm Biopharm; 2020 Nov; 156():191-202. PubMed ID: 32941997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically-Based Pharmacokinetic Modeling to Support Determination of Bioequivalence for Dermatological Drug Products: Scientific and Regulatory Considerations.
    Tsakalozou E; Alam K; Babiskin A; Zhao L
    Clin Pharmacol Ther; 2022 May; 111(5):1036-1049. PubMed ID: 34231211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.